MLMargret I. Lenfest

Margret I. Lenfest

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Margret I. Lenfest has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Timed Up and Go test predicts survival but not hospitalization or mobility concerns at the end of life in a population of geriatric dogs

    by Abigail E. Woods, Mark Rishniw, Karolynn M. Ellis, Kelly M. McMullin, Ivanka G. Juran, Kurt R. Venator, Allison V. Miller, Margret I. Lenfest, Christopher W. Frye

    Objective: To examine the Timed Up and Go (TUG) test in geriatric dogs as a predictive measure of survival, hospitalization, and owner concern regarding end-of-life mobility. Methods: The owners of 83 geriatric dogs that had successfully completed a TUG test between April and September of 2023 were solicited to answer a survey regarding their dog, administered in June of 2025. Surveys recorded the dates (rounded to the nearest month) of deaths and hospitalizations and ranked owner mobility concerns at end of life. Data were excluded if dogs had died within 2 weeks of their TUG test or surveys were incomplete. A post hoc analysis was conducted to investigate the predictive utility of the TUG test against all-cause mortality and select morbidity measures. Results: 82 surveys and paired TUG times were analyzed. The median dog age was 11 years (range, 8 to 17 years) and median weight was 26.4 kg (range, 2.6 to 46.4 kg). The TUG times ranged from 1.72 to 14.19 seconds. Dogs with a TUG ≥ 7 seconds had a shorter median survival (14 months) than dogs scoring < 7 seconds (incalculable). In multivariable Cox proportional hazard analysis, only TUG demonstrated an instantaneous hazard of death risk, increasing 15% for each 1-second increase in TUG time. The TUG time failed to predict hospitalization or owner end-of-life mobility concerns. Conclusions: Longer TUG times predict all-cause mortality but not morbidity in a group of geriatric dogs. Clinical Relevance: The TUG test may be useful for identifying geriatric dogs at greater risk of mortality for proactive clinical intervention or quality-of-life conversations.

  • Open Access

    Diagnosis of canine elbow dysplasia and treatment with extracorporeal shockwave therapy

    by Margret I. Lenfest, Carol Jennings, Alina J. Randolph, Ian Porter, David Levine

    Objective: To provide a video tutorial on assessment and diagnosis of canine elbow dysplasia and treatment with extracorporeal shockwave therapy. Animals: Dogs undergoing shockwave therapy for therapeutic purpose. Methods: Assess the patient through gait analysis and examination. Elbow discomfort is investigated with diagnostic imaging (CT scan or orthogonal radiographs) to confirm a diagnosis of elbow dysplasia and secondary osteoarthritis. Prepare the elbow for treatment by shaving the hair over the target anatomy, cleaning the skin with 70% isopropyl alcohol, and applying coupling gel. Select appropriate shockwave settings and standoff for the patient. Position the trode perpendicular to the medial elbow joint and deliver the treatment while slowly moving the trode over the medial humeral epicondyle, medial coronoid process, and medial joint capsule attachments. Repeat the process on the lateral aspect of the elbow. The treatment can be repeated in the contralateral elbow if indicated. Record treatment including the number of shocks delivered and energy flux density in mJ/mm 2 . Shockwave therapy can be prescribed as a series of 3 treatments followed by reassessment. Assessment after a treatment series is necessary to quantify response to the therapy and determine whether treatment should be continued. Results: Shockwave therapy is a noninvasive therapy that causes the release of growth factors and anti-inflammatory cytokines that improve analgesia and encourage better healing. Clinical Relevance: Shockwave is a simple noninvasive therapeutic option for management of secondary elbow osteoarthritis. With appropriate diagnosis of the underlying condition, shockwave can be easily applied to the target anatomy for maximal analgesic effect and functional improvement.